A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration – National Academies Press – 2011

Posted on May 10, 2011. Filed under: Pharmacy | Tags: , |

A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration – National Academies Press – 2011

Authors: Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II; National Research Council

ISBN-10: 0-309-21280-4
ISBN-13: 978-0-309-21280-9

“This report, prepared by the Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II, in response to the request from FDA and DHHS, describes a risk characterization framework that can be used to evaluate and compare the public-health consequences of different decisions concerning a wide variety of products.”

Advertisements

Make a Comment

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Liked it here?
Why not try sites on the blogroll...

%d bloggers like this: